Tabzolv Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 18 years ago on Thursday, September 15, 2005, according to the United State Patent & Trademark Office
Word Mark Tabzolv
Status Dead 606 — Abandoned - No Statement of Use Filed

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 78288453
Status Date Thursday, September 15, 2005
Filing Date Thursday, September 15, 2005

Correspondent

Nadine P. Flynn, Esq.
Bristol-Myers Squibb Company
345 Park Avenue
New York, NY 10154

Case File Statements

Goods & Services Pharmaceutical preparations for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants
Pseudo Mark Tabs Solve

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Thursday, August 28, 2003
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.